Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE) Source: International Congress 2016 – Pleural diseases Year: 2016
Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
Epidemiology of pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=146 Year: 2002
Malignant pleural effusions: diagnosis and management Source: International Congress 2017 – PG5 Pleural disease management Year: 2017
Malignant pleural effusions: from the diagnosis to the management Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management Year: 2015
Tuberculous pleural effusion Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
The role of a pleural service in optimising pleural disease management Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
Management of malignant pleural effusions Source: Guideline 2001 Year: 2001
Management of malignant pleural effusions Source: Eur Respir J 2001; 18: 402-419 Year: 2001
Management of malignant pleural effusions Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
Epidemiology, etiology, prognosis and presentation of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
Diagnostic values of inflammation biomarkers in pleural effusions (PE) Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015
Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
Diagnostic yield of the new pleural biopsy needle ((Esmat’s needle)) in exudative pleural effusion Source: International Congress 2016 – Pleural diseases Year: 2016